This inventor holds 8 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Innovations of Timothy J Senter
Introduction
Timothy J Senter is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for kidney diseases.
Latest Patents
Senter holds six patents, with his latest innovations focusing on inhibitors of APOL1. These patents disclose compounds that can be used in treating APOL1-mediated diseases, including pancreatic cancer, focal segmental glomerulosclerosis (FSGS), and non-diabetic kidney disease (NDKD). The disclosures provide at least one entity chosen from compounds of Formula I, a tautomer thereof, a deuterated derivative of that compound or tautomer, and a pharmaceutically acceptable salt of any of the foregoing.
Career Highlights
Timothy J Senter is currently employed at Vertex Pharmaceuticals, Inc., where he continues to advance his research and development efforts in the pharmaceutical industry. His work has been instrumental in addressing critical health issues related to kidney diseases.
Collaborations
Some of his notable coworkers include Jingrong Cao and Jon H Come, who collaborate with him on various projects within the company.
Conclusion
Timothy J Senter's innovative work in the field of pharmaceuticals highlights his commitment to improving health outcomes through targeted treatments. His contributions are paving the way for advancements in the treatment of serious medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile